321 related articles for article (PubMed ID: 24300620)
1. Cell-based therapies for the acute respiratory distress syndrome.
Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
[TBL] [Abstract][Full Text] [Related]
2. Stem cell therapy for acute respiratory distress syndrome: a promising future?
Horie S; Masterson C; Devaney J; Laffey JG
Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cell therapies: potential and pitfalls for ARDS.
Masterson C; Jerkic M; Curley GF; Laffey JG
Minerva Anestesiol; 2015 Feb; 81(2):179-94. PubMed ID: 24492665
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome.
Cárdenes N; Cáceres E; Romagnoli M; Rojas M
Respiration; 2013; 85(4):267-78. PubMed ID: 23428562
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome.
Matthay MA
Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S54-7. PubMed ID: 25830837
[TBL] [Abstract][Full Text] [Related]
6. Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value.
Laffey JG; Matthay MA
Am J Respir Crit Care Med; 2017 Aug; 196(3):266-273. PubMed ID: 28306336
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
Walter J; Ware LB; Matthay MA
Lancet Respir Med; 2014 Dec; 2(12):1016-26. PubMed ID: 25465643
[TBL] [Abstract][Full Text] [Related]
8. The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome.
Antebi B; Mohammadipoor A; Batchinsky AI; Cancio LC
J Trauma Acute Care Surg; 2018 Jan; 84(1):183-191. PubMed ID: 29019797
[TBL] [Abstract][Full Text] [Related]
9. Intravenous transplantation of mesenchymal stem cells attenuates oleic acid induced acute lung injury in rats.
Xu YL; Liu YL; Wang Q; Li G; Lü XD; Kong B
Chin Med J (Engl); 2012 Jun; 125(11):2012-8. PubMed ID: 22884070
[TBL] [Abstract][Full Text] [Related]
10. Acute respiratory distress syndrome and acute lung injury.
Dushianthan A; Grocott MP; Postle AD; Cusack R
Postgrad Med J; 2011 Sep; 87(1031):612-22. PubMed ID: 21642654
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell trials for pulmonary diseases.
Antunes MA; Laffey JG; Pelosi P; Rocco PR
J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
[TBL] [Abstract][Full Text] [Related]
12. Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome.
Horie S; Laffey JG
F1000Res; 2016; 5():. PubMed ID: 27408702
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
14. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome.
Han J; Liu Y; Liu H; Li Y
Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004
[TBL] [Abstract][Full Text] [Related]
15. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
Curley GF; O'Kane CM; McAuley DF; Matthay MA; Laffey JG
Am J Respir Crit Care Med; 2024 Apr; 209(7):789-797. PubMed ID: 38324017
[TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells in regeneration after acute lung injury: do they play a role?
Rafat N; Tönshoff B; Bierhaus A; Beck GC
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):399-405. PubMed ID: 23103996
[TBL] [Abstract][Full Text] [Related]
17. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome.
Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P
Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828
[TBL] [Abstract][Full Text] [Related]
18. Current knowledge of acute lung injury and acute respiratory distress syndrome.
Dechert RE; Haas CF; Ostwani W
Crit Care Nurs Clin North Am; 2012 Sep; 24(3):377-401. PubMed ID: 22920464
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.
Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalén M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OP; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson PO; Hägglund H; Mattsson M; Lehtiö J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo KH; Le Blanc K
Stem Cells Transl Med; 2015 Oct; 4(10):1199-213. PubMed ID: 26285659
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer.
Morrison TJ; Jackson MV; Cunningham EK; Kissenpfennig A; McAuley DF; O'Kane CM; Krasnodembskaya AD
Am J Respir Crit Care Med; 2017 Nov; 196(10):1275-1286. PubMed ID: 28598224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]